Kevin Bottomley

Kevin Bottomley discloses dealings in True Leaf Medicine International Ltd. to SEDI. The record holds 50 filings, for trades running from 9 February 2016 to 12 March 2019.

The open-market side counts 16 purchases for €35k alongside 26 sales for €240k. Taken together, the sales exceed the purchases by €204k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 option exercises. In 2019 alone, the filings show no purchases and 2 sales.

In size, the median ticket on the buying side is €1,014. None of the 16 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 13 March 2019, the filings show an open-market sale worth €3,648 in True Leaf Medicine International Ltd. The last purchase on record was published on 9 August 2017, which is 3,365 days ago. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.